EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Engineering the future of medicine: Natural products, synthetic biology and artificial intelligence for next‐generation therapeutics

Emre F Bülbül, Helge B Bode, Steven Schmitt, Kenan A J Bozhüyük iD

Clinical and Translational Medicine · 2025

DOI: 10.1002/ctm2.70146 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Emre F Bülbül und 3 weiteren Autor:innen. Beteiligte Einrichtung: Synthetic Biology of Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Rese…. Hauptthemen laut MEDLINE: Artificial Intelligence, Synthetic Biology, Biological Products. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The e X change U nit between T hiolation domains approach and artificial intelligence (AI)‐driven tools like Synthetic Intelligence are transforming nonribosomal peptide synthetase and polyketide synthase engineering, enabling the creation of novel bioactive compounds that address critical challenges like antibiotic resistance and cancer. These innovations expand chemical space and optimize biosynthetic pathways, offering precise and scalable therapeutic solutions. Collaboration across synthetic biology, AI, and clinical research is essential to translating these breakthroughs into next‐generation treatments and revolutionizing drug discovery and patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceSynthetic BiologyBiological ProductsHumansDrug Discovery

Stichwörter der Autor:innen

AIbioengineeringnatural productssynthetic biology

Substanzen

Biological Products

Autor:innen und Institutionen

  • Synthetic Biology of Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarbrücken, Germany.
  • Department of Natural Products in Organismic Interactions, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
  • Department of Biosciences, Molecular Biotechnology, Goethe-University Frankfurt, Frankfurt, Germany.
  • Center for Synthetic Microbiology (SYNMIKRO), Phillips University Marburg, Marburg, Germany.
  • Department of Chemistry, Phillips University Marburg, Marburg, Germany.
  • LOEWE Centre for Translational Biodiversity Genomics (LOEWE-TBG) & Senckenberg Gesellschaft für Naturforschung, Frankfurt, Germany.

ORCID-Profile: Kenan A J Bozhüyük

Zitieren

APA

Bülbül, E. F., Bode, H. B., Schmitt, S., & Bozhüyük, K. A. J. (2025). Engineering the future of medicine: Natural products, synthetic biology and artificial intelligence for next‐generation therapeutics. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70146

Vancouver

Bülbül EF, Bode HB, Schmitt S, Bozhüyük KAJ. Engineering the future of medicine: Natural products, synthetic biology and artificial intelligence for next‐generation therapeutics. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70146

BibTeX
@article{Blbl2025,
  author = {Bülbül, Emre F and Bode, Helge B and Schmitt, Steven and Bozhüyük, Kenan A J},
  title = {Engineering the future of medicine: Natural products, synthetic biology and artificial intelligence for next‐generation therapeutics},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  doi = {10.1002/ctm2.70146}
}
Kostenlos starten →